Hepatocellular carcinoma (HCC) is one of the most common causes of cancer‐related
deaths globally due, in part, to the majority of patients being diagnosed with intermediate or …

Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

Abstract Background: Hepatocellular carcinoma (HCC)(about 85–90% of primary liver
cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Liver transplantation (LT) offers excellent long-term outcome for certain patients with
hepatocellular carcinoma (HCC), with a push to not simply rely on tumor size and number …

BACKGROUND & AIMS: The aim of this study was to generate an improved prognostic
model for predicting recurrence in liver transplant candidates with hepatocellular carcinoma …

Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

Although liver transplantation is a widely accepted treatment for hepatocellular carcinoma
(HCC), much controversy remains and there is no generally accepted set of guidelines. An …

Hepatocellular carcinoma (HCC) is the seventh most common cancer worldwide and the
third most common cause of cancer-related deaths; the number of new cases per year is …

Standard for diagnosis and treatment of primary liver cancer (2022 edition) 中文|English ISSN
1001-5256 (Print) ISSN 2097-3497 (Online) CN 22-1108/R Home About Journal 1.Journal …